Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood|September 22, 2023
Reinforced antimyeloma therapy via dual-lymphoid activation mediated by a panel of antibodies armed with bridging-BiTETatsuya Konishi, Toshiki Ochi, Masaki Maruta, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 29, 2026
[Sustained hematologic complete response after discontinuation of ropeginterferon alfa-2b in patients with polycythemia vera]Masaki Maruta, Kento Mori, Koji Oka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2025
[Challenges and Prospects for Medical Oncology under the Emerging Infectious Disease Disaster]Sachi Morita, Noritoshi Kobayashi, Junji Tsurutani, et al.
Journal of Clinical Epidemiology|July 4, 2021
Quality of clinical practice guidelines in Japan remains low: A cross-sectional meta-epidemiological studyYuki Kataoka, Keisuke Anan, Shunsuke Taito, et al.
Transplantation and Cellular Therapy|October 7, 2025
Impact of Oral Eicosapentaenoic Acid on Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Onset Prevention: Single-Center Retrospective AnalysisYukihiro Miyazaki, Hiroshi Narumi, Taichi Azuma, et al.
Journal for Immunotherapy of Cancer|June 24, 2025
Bystander CAR<sup>-</sup>CD8<sup>+</sup> T cells in a CAR-T cell product can expand and enhance the antitumor effects of a bispecific antibodyJunichi Kato, Tatsuya Konishi, Takatsugu Honda, et al.
Frontiers in Immunology|May 8, 2026
Case Report: Compromised response of memory-formed bystander T cells after CD19 CAR-T cell therapy following CD20 bispecific antibody therapyYuya Masuda, Junichi Kato, Tatsuya Konishi, et al.
Cytotherapy|October 29, 2025
Comparison of stem cell mobilization methods in multiple myelomaYutaka Shimazu, Nobuhiro Tsukada, Masaki Maruta, et al.
Cancer Science|July 22, 2024
Interim PET-guided ABVD or ABVD/escalated BEACOPP for newly diagnosed advanced-stage classic Hodgkin lymphoma (JCOG1305)Shigeru Kusumoto, Wataru Munakata, Ryunosuke Machida, et al.
Cancer Chemotherapy and Pharmacology|January 24, 2025
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1)Masaki Ri, Shinsuke Iida, Kosuke Saito, et al.
Pageof 2